Yuyu Pharma Statistics

Total Valuation

Yuyu Pharma has a market cap or net worth of KRW 68.53 billion. The enterprise value is 79.92 billion.

Market Cap	68.53B
Enterprise Value	79.92B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Yuyu Pharma has 16.18 million shares outstanding. The number of shares has increased by 5.80% in one year.

Current Share Class	n/a
Shares Outstanding	16.18M
Shares Change (YoY)	+5.80%
Shares Change (QoQ)	-8.90%
Owned by Insiders (%)	34.99%
Owned by Institutions (%)	0.29%
Float	10.52M

Valuation Ratios

The trailing PE ratio is 40.66.

PE Ratio	40.66
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.59
P/TBV Ratio	n/a
P/FCF Ratio	5.76
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.57, with an EV/FCF ratio of 6.72.

EV / Earnings	46.29
EV / Sales	0.59
EV / EBITDA	6.57
EV / EBIT	12.34
EV / FCF	6.72

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.28.

Current Ratio	1.63
Quick Ratio	0.92
Debt / Equity	0.28
Debt / EBITDA	2.82
Debt / FCF	3.00
Interest Coverage	2.59

Financial Efficiency

Return on equity (ROE) is 3.81% and return on invested capital (ROIC) is 2.62%.

Return on Equity (ROE)	3.81%
Return on Assets (ROA)	2.19%
Return on Capital (ROIC)	2.62%
Revenue Per Employee	534.71M
Profits Per Employee	6.82M
Employee Count	253
Asset Turnover	0.68
Inventory Turnover	1.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.87% in the last 52 weeks. The beta is 0.51, so Yuyu Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-13.87%
50-Day Moving Average	4,492.30
200-Day Moving Average	4,810.55
Relative Strength Index (RSI)	44.00
Average Volume (20 Days)	54,932

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Yuyu Pharma had revenue of KRW 135.28 billion and earned 1.73 billion in profits. Earnings per share was 104.17.

Revenue	135.28B
Gross Profit	49.27B
Operating Income	6.97B
Pretax Income	4.90B
Net Income	1.73B
EBITDA	12.66B
EBIT	6.97B
Earnings Per Share (EPS)	104.17

Full Income Statement

Balance Sheet

The company has 36.22 billion in cash and 35.65 billion in debt, giving a net cash position of 562.60 million or 34.77 per share.

Cash & Cash Equivalents	36.22B
Total Debt	35.65B
Net Cash	562.60M
Net Cash Per Share	34.77
Equity (Book Value)	127.90B
Book Value Per Share	7,165.26
Working Capital	39.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.07 billion and capital expenditures -5.17 billion, giving a free cash flow of 11.90 billion.

Operating Cash Flow	17.07B
Capital Expenditures	-5.17B
Free Cash Flow	11.90B
FCF Per Share	735.25

Full Cash Flow Statement

Margins

Gross margin is 36.42%, with operating and profit margins of 5.15% and 1.92%.

Gross Margin	36.42%
Operating Margin	5.15%
Pretax Margin	3.62%
Profit Margin	1.92%
EBITDA Margin	9.36%
EBIT Margin	5.15%
FCF Margin	8.80%

Dividends & Yields

Yuyu Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.80%
Shareholder Yield	-5.80%
Earnings Yield	2.46%
FCF Yield	17.36%

Dividend Details

Stock Splits

The last stock split was on March 30, 2021. It was a forward split with a ratio of 2.

Last Split Date	Mar 30, 2021
Split Type	Forward
Split Ratio	2

Scores

Yuyu Pharma has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.91
Piotroski F-Score	n/a